On October 19, Aehr Test rose 8.21% in Pre-Market Trading, trading around $65.03, with turnover of $4.33 million.
The move followed market digestion of competitive concerns after Teradyne introduced Titan HP, while a latest analyst view said Aehr Test's earlier selloff was overdone and now presents a buying opportunity.
Recent company developments provide fundamental support: over the past two months, Aehr Test disclosed a $22 million follow-on production order from a lead wafer-level AI processor customer, about $6 million in follow-on orders for AI chip testing equipment for data-center training and inference processors, and continued expansion orders from a silicon photonics customer. Those updates suggest demand for AI test and burn-in equipment remains active even as investors reassess the competitive landscape.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments